Go to main content
EU law of competition and trade in the pharmaceutical sector / edited by Pablo Figueroa (Partner and Head of EU and Competition, Garrido Abogados Spain, Lecturer, Queen Mary University, London, UK) and Alejandro Guerrero (Of Counsel, Gibson, Dunn & Crutcher LLP, Belgium).
Figueroa, Pablo, editor.; Guerrero, Alejandro, editor.; Edward Elgar Publishing, publisher.
2019
INTERNET
Available Online
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS
Add to Basket

Details

E-resource Policy
Linked Resources
Edward Elgar
Title
EU law of competition and trade in the pharmaceutical sector / edited by Pablo Figueroa (Partner and Head of EU and Competition, Garrido Abogados Spain, Lecturer, Queen Mary University, London, UK) and Alejandro Guerrero (Of Counsel, Gibson, Dunn & Crutcher LLP, Belgium).
Published
Northampton, MA : Edward Elgar Pub., 2019.
Call Number
INTERNET
ISBN
9781785362613 (e-book)
Description
1 online resource (816 pages).
System Control No.
eep9781785362613
Summary
This book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-profile competition enforcers, this work provides valuable insider knowledge on the application of competition law and policies to the pharmaceutical industry. Key features include: Extensive commentary on the legislation and the latest case law and administrative precedents in the pharmaceutical sector, at both EU and national level; Coverage of various key developments including the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturers; In-depth analysis of topics commonly raised in the pharmaceutical sector including: pricing policies, IP life-cycle management, IP licensing and horizontal cooperation agreements; Key economic and business perspectives to accompany legal analysis, providing the reader with a rounded view of the subject matter. This book will be a useful resource for lawyers and in-house counsel active in the pharmaceutical sector. The information and analysis provided will prepare readers to take on cases and drive the antitrust review of transactions and agreements within the industry. Researchers, economists and civil servants with an interest in competition law and trade regulation can also benefit from the practical insights provided therein.
Note
Includes index.
Digital File Characteristics
text file
Source of Description
Description based on print record.
Series
Elgar competition law and practice.
Record Appears in
Remotely Accessible Online Resources
All Resources
Added Author
Figueroa, Pablo, editor.
Guerrero, Alejandro, editor.
Added Corporate Author
Edward Elgar Publishing, publisher.
Contents: 1. Competition law and pharma: an economic perspective / Benoît Durand
2. Reverse payments: an EU and U.S. Perspective / Frank Maier-Rigaud, Nathan Blalock and Oliver Gannon
3. Article 101 TFEU : horizontal cooperation agreements in the pharmaceutical sector / Soledad Blanco Thomas, Lilia Luchianov and Thomas Weck
4. The competitive assessment of IP licensing agreements in the pharmaceutical sector / Pierre Moullet
5. Article 102 TFEU : patent filings as an abuse of dominant position after "AstraZeneca": the patent / antitrust interface under a new perspective / Francisco Hernández
6. Mergers in the pharmaceutical sector / Pablo Figueroa and Alejandro Guerrero
7. Mergers in the medical devices sector / Jan Heithecker
8. Antitrust practices in pharmaceutical public procurement / Antonio Minho López
9. EU trade law and pharmaceuticals / Pascale Hecker
10. The pharmaceutical sector and parallel trade / Edurne Navarro Varona and Cristina Caballero
11. Free movement and competition in the European market for pharmaceuticals / Pedro Caro de Sousa
12. IP law and pharmaceuticals: patents and supplementary protection certificates in the pharmaceutical sector / Rais Amils
13. The EU regulatory framework for medical products for human use / Marc Martens and Nicolas Carbonnelle
14. Antitrust and the pharmaceutical industry in the United States / George A. Hay
15. UK competition and trade in the pharma sector / Paula Riedel
16. Competition law and pharma: China / Andrew Foster
17. Competition law and pharma: Spain / Helmut Brokelmann and Mariarosaria Ganino
18. The application of competition law in the pharmaceutical sector: challenges for BRICS / Maria Ioannidou and Ioannis Kokkoris
19. Product hopping: the U.S. approach / Michael A. Carrier
20. Marketing data in the pharmaceutical sector: a competition law consideration / Pedro Callol
Index.

Browse Subjects

Show more subjects...